var title_f37_58_38816="Levocabastine: Patient drug information";
var content_f37_58_38816=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Levocabastine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F12931255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12931256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/55/43891?source=see_link\">",
"       Levocabastine (nasal): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/62/41955?source=see_link\">",
"       Levocabastine (ophthalmic): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16762 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-6F9A708CB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38816=[""].join("\n");
var outline_f37_58_38816=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/55/43891?source=related_link\">",
"      Levocabastine (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/62/41955?source=related_link\">",
"      Levocabastine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_58_38817="Aseptic prosthetic loosening";
var content_f37_58_38817=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F56858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F56858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Aseptic loosening of left hip prosthesis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 412px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Frontal radiograph of the pelvis shows radiolucent areas greater than 2 mm surrounding the proximal shaft of the left femoral prosthesis, consistent with loosening (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cecilia M Jude, MD, and Shahla Modarresi, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38817=[""].join("\n");
var outline_f37_58_38817=null;
var title_f37_58_38818="Urinary tract infections in children";
var content_f37_58_38818=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Urinary tract infections in children (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?37/58/38818/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/58/38818/contributors\" id=\"au6289\">",
"       Nader Shaikh, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/58/38818/contributors\" id=\"au6234\">",
"       Alejandro Hoberman, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?37/58/38818/contributors\">",
"       Section Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/58/38818/contributors\" id=\"se6305\">",
"       Tej K Mattoo, MD, DCH, FRCP",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/58/38818/contributors\" id=\"se4583\">",
"       Morven S Edwards, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?37/58/38818/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/58/38818/contributors\" id=\"de5754\">",
"       Mary M Torchia, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?37/58/38818?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      URINARY TRACT INFECTION OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     The urinary system includes two kidneys (that filter urine), two ureters (that move urine from the kidneys to the bladder), the bladder (that holds urine), and the urethra (that carries urine out of the bladder) (",
"     <a class=\"graphic graphic_figure graphicRef65630 \" href=\"mobipreview.htm?14/27/14769\">",
"      figure 1",
"     </a>",
"     ). Bacteria (germs) do not normally live in these areas. When bacteria enter the bladder or kidneys, an infection can develop. These infections are called urinary tract infections (UTI).",
"    </p>",
"    <p>",
"     Kidney infections are the most serious type of UTI because, if not treated quickly, the infection can permanently damage the kidneys. Damage to the kidney can lead to high blood pressure and kidney failure later in life.",
"    </p>",
"    <p>",
"     Urinary tract infections in adolescents and adults are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/18/32036?source=see_link\">",
"      \"Patient information: Urinary tract infections in adolescents and adults (Beyond the Basics)\"",
"     </a>",
"     .) More detailed information about urinary tract infections in children is available by subscription. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link\">",
"      \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=see_link\">",
"      \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/59/42937?source=see_link\">",
"      \"Acute cystitis in children older than two years and adolescents\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      URINARY TRACT INFECTION CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     In healthy children, most urinary tract infections (UTI) are caused by",
"     <em>",
"      Escherichia coli",
"     </em>",
"     (",
"     <em>",
"      E. coli",
"     </em>",
"     ) bacteria, which are normally found in stool. These bacteria can move from the anus to the urethra and into the bladder (and sometimes up into the kidney) causing infection.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Risk factors",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some children have a higher chance of developing a UTI. The following are some risk factors for UTI:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Young age; boys younger than one year old, and girls younger than four years of age are at highest risk.",
"      </li>",
"      <li>",
"       Being uncircumcised; there is a four to 10 times higher risk of UTIs in uncircumcised boys. Still, most uncircumcised boys do NOT develop UTIs. (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/5/1107?source=see_link\">",
"        \"Patient information: Circumcision in baby boys (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Having a bladder catheter for a prolonged period of time.",
"      </li>",
"      <li>",
"       Having parts of the urinary tract that did not form correctly before birth.",
"      </li>",
"      <li>",
"       Having a bladder that does not work properly.",
"      </li>",
"      <li>",
"       Having one UTI increases the chance of getting another UTI.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      URINARY TRACT INFECTION SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Symptoms of a urinary tract infection depend on the child's age.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Older children",
"     </span>",
"     &nbsp;&mdash;&nbsp;Children older than two years often have:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Pain or burning when urinating",
"      </li>",
"      <li>",
"       Frequent need to urinate",
"      </li>",
"      <li>",
"       Pain in the lower abdomen or sides of the back (",
"       <a class=\"graphic graphic_figure graphicRef54658 \" href=\"mobipreview.htm?12/35/12848\">",
"        figure 2",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Fever (higher than 100.4&ordm;F or 38&ordm;C) (see",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/23/37235?source=see_link\">",
"        \"Patient information: Fever in children (Beyond the Basics)\"",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Younger children",
"     </span>",
"     &nbsp;&mdash;&nbsp;Symptoms in children younger than two years may include one or more of the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Fever, which may be the only symptom",
"      </li>",
"      <li>",
"       Vomiting or diarrhea",
"      </li>",
"      <li>",
"       Irritability or fussiness",
"      </li>",
"      <li>",
"       Poor feeding, poor weight gain",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      URINARY TRACT INFECTION DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     If you are concerned that your child has a urinary tract infection (UTI), make an appointment with the child's doctor or nurse within 24 hours. Waiting to start treatment can increase the risk of damage to the kidneys.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Urine testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;A urine sample is needed to determine if the child has a UTI. In young children who are not toilet trained, it is usually necessary to insert a thin sterile tube (a catheter) into the bladder to obtain a urine sample.",
"    </p>",
"    <p>",
"     In older children who can use the toilet, you can collect a urine sample by having the child urinate into a sterile cup.",
"    </p>",
"    <p>",
"     After obtaining the urine, a urine dipstick test is usually done in the office. If the test is positive for a UTI, the doctor or nurse will send the urine sample to a lab for urine culture to confirm the diagnosis. The culture helps decide which antibiotic is best. It takes up to 48 hours for germs to grow, so the culture results are not available right away.",
"    </p>",
"    <p>",
"     Based on the child's symptoms and the results of the dipstick test, the doctor or nurse may decide to start antibiotics before urine culture results are available.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Imaging tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;Imaging tests, such as ultrasound or x-ray, can show if a child's urinary system did not form correctly before birth. If the urinary system is abnormal, a child is more likely to have UTIs. Testing may include a kidney ultrasound and a voiding cystourethrogram (VCUG). Imaging tests are generally done in younger children (less than three to five years old) or in children who have had more than one UTI.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Kidney ultrasound",
"     </span>",
"     &nbsp;&mdash;&nbsp;Ultrasound uses sound waves to create a picture of the kidneys. During the test, gel is applied to the skin on the child's back and abdomen and a small wand-like device is pressed against the body. The test is not painful and usually takes less than 30 minutes.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Voiding cystourethrogram",
"     </span>",
"     &nbsp;&mdash;&nbsp;A voiding cystourethrogram (VCUG) is an x-ray test that shows the outline of the child's bladder and urethra. The test can also show if urine flows from the bladder backwards into the ureters or kidneys; this is called vesicoureteral reflux. Reflux may increase the chance that a child will have kidney infections.",
"    </p>",
"    <p>",
"     This test takes about one to two hours to complete and involves putting a catheter into the child's bladder. Dye is put into the child's bladder through the catheter and x-rays are taken before and after the child urinates.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      URINARY TRACT INFECTION TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     Antibiotics are used to treat urinary tract infections (UTI). The best antibiotic depends upon the child's age, the germ that caused the UTI, and the resistance that germs have. Most children who are older than two months are given an antibiotic by mouth, in a liquid or chewable tablet.",
"    </p>",
"    <p>",
"     If the child is less than two months old, or if the child is vomiting and unable to take medicine by mouth, it may be necessary for the child to be admitted to the hospital for treatment with intravenous (IV) antibiotics.",
"    </p>",
"    <p>",
"     Antibiotics are usually prescribed for a total of 5 to 10 days. In all cases, it is important for the child to take each dose of the antibiotic on time and to finish all of the medicine.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Response to treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Your child should begin to feel better within 24 to 48 hours of starting antibiotics. If your child does not get better or worsens, he or she should be seen again by a doctor or nurse. Most children who have a UTI have no long-term damage to the urinary tract from the infection. It is not necessary to have another urine test after a child has finished antibiotic treatment, as long as the UTI symptoms have resolved.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h1\">",
"      URINARY TRACT INFECTION PREVENTION",
"     </span>",
"    </p>",
"    <p>",
"     About 8 to 30 percent (1 in 5 to 10) of children who have a urinary tract infection (UTI) develop another UTI. This usually happens within the first six months after the first infection and is more common in girls. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/27/7606?source=see_link\">",
"      \"Long-term management and prevention of urinary tract infections in children\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Treatment of constipation and bladder problems will also help prevent future UTIs.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Preventive antibiotics",
"     </span>",
"     &nbsp;&mdash;&nbsp;A low daily dose of an antibiotic may be recommended if your child gets frequent UTIs. This treatment is usually continued for 6 to 12 months.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      WHEN TO SEEK HELP",
"     </span>",
"    </p>",
"    <p>",
"     If your child has any of the following, make an appointment with his or her doctor or nurse:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Fever &ndash; Fever (temperature higher than 100.4&ordm;F or 38&ordm;C) may be the only symptom of urinary tract infection in infants and young children. In addition, any young child who develops a fever and has had a urinary tract infection (UTI) before should be seen within 24 hours.",
"      </li>",
"      <li>",
"       Pain or burning with urination or frequent urination.",
"      </li>",
"      <li>",
"       Back or abdominal pain.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your child's healthcare provider is the best source of information for questions and concerns related to your child's medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1784797840\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3357387\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/47/20210?source=see_link\">",
"      Patient information: Urinary tract infections in adults (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/2/21538?source=see_link\">",
"      Patient information: Daytime wetting (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?10/38/10850?source=see_link\">",
"      Patient information: Urinary tract infections in children (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/19/38193?source=see_link\">",
"      Patient information: Vesicoureteral reflux in children (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3357413\">",
"     <span class=\"h3\">",
"      Beyond the basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/18/32036?source=see_link\">",
"      Patient information: Urinary tract infections in adolescents and adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/5/1107?source=see_link\">",
"      Patient information: Circumcision in baby boys (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/23/37235?source=see_link\">",
"      Patient information: Fever in children (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/59/42937?source=see_link\">",
"      Acute cystitis in children older than two years and adolescents",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/41/38552?source=see_link\">",
"      Acute management of nephrolithiasis in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=see_link\">",
"      Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/19/13623?source=see_link\">",
"      Clinical features and diagnosis of nephrolithiasis in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link\">",
"      Clinical features and diagnosis of urinary tract infections in infants and children older than one month",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26360?source=see_link\">",
"      Epidemiology and risk factors for urinary tract infections in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/29/43479?source=see_link\">",
"      Evaluation of dysuria in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/27/7606?source=see_link\">",
"      Long-term management and prevention of urinary tract infections in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/62/41961?source=see_link\">",
"      Management of vesicoureteral reflux",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/10/3242?source=see_link\">",
"      Presentation, diagnosis, and clinical course of vesicoureteral reflux",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/62/19432?source=see_link\">",
"      Prevention of recurrent nephrolithiasis in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/59/14264?source=see_link\">",
"      Urinary tract infections in newborns",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/56/42886?source=see_link\">",
"      Urine collection techniques in children",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/ency/article/000505.htm\">",
"      www.nlm.nih.gov/medlineplus/ency/article/000505.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Diabetes and Digestive and Kidney Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://kidney.niddk.nih.gov/kudiseases/pubs/utichildren/\">",
"      file://kidney.niddk.nih.gov/kudiseases/pubs/utichildren/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?37/58/38818/abstract/1,2\">",
"      1,2",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 13, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?37/58/38818?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38818/abstract/1\">",
"      Williams GJ, Wei L, Lee A, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev 2006; :CD001534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38818/abstract/2\">",
"      Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128:595.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f37_58_38818=[""].join("\n");
var outline_f37_58_38818=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           URINARY TRACT INFECTION OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           URINARY TRACT INFECTION CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           URINARY TRACT INFECTION SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           URINARY TRACT INFECTION DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           URINARY TRACT INFECTION TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H14\">",
"           URINARY TRACT INFECTION PREVENTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           WHEN TO SEEK HELP",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/27/14769\" title=\"figure 1\">",
"           Urinary anatomy pedi PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/35/12848\" title=\"figure 2\">",
"           Flank pain child PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f37_58_38819="Ultrasound depth selection";
var content_f37_58_38819=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81876&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81876&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Importance of proper ultrasound depth selection for vascular access",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 438px; height: 564px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transverse ultrasound images of the right arm demonstrate the importance of proper image parameter selection. A) Poor image quality due to excessive depth (green arrow) and improperly positioned focal zone (asterisk). Note signal dropout in the lower half of the image, as the high frequency transducer cannot penetrate to 8 cm depth. B) Improved image quality with properly selected depth (green arrow) and focal zone (asterisk). There is now detailed resolution of the brachial artery (red arrow), paired brachial veins (blue arrows) and the biceps muscle. The humerus is also seen as a bright curved line deep to the vessels.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lauren W Averill, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38819=[""].join("\n");
var outline_f37_58_38819=null;
var title_f37_58_38820="Sodium, potassium and magnesium sulfates bowel preparation kit: Drug information";
var content_f37_58_38820=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sodium, potassium and magnesium sulfates bowel preparation kit: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?36/37/37460?source=see_link\">",
"    see \"Sodium, potassium and magnesium sulfates bowel preparation kit: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F11238875\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Suprep&reg; Bowel Prep Kit",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F11238904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Laxative, Osmotic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F11239124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Bowel cleansing prior to GI exam:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Split-dose regimen: Total volume of liquid consumed over the course of treatment: 2880 mL (96 oz)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Evening before colonoscopy: Drink the entire contents of 1 bottle, diluted to a final volume of 480 mL (16 oz). Then drink 2 additional containers of water each (filled to the 16-ounce line) over the next hour, for an additional volume of 960 mL (32 oz).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Morning of the colonoscopy (10-12 hours after the evening dose): Repeat entire process with the second bottle: Drink entire contents of second bottle diluted to a final volume of 480 mL (16 oz); then drink 2 additional containers of water (each filled to the 16-ounce line) over the next hour, for an additional volume of 960 mL (32 oz). Complete at least 2 hours before the procedure.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F11239125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F11368444\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Suprep&reg; Bowel Prep Kit: Sodium sulfate 17.5 g, potassium sulfate 3.13 g,  and magnesuim sulfate 1.6 g  per 180 mL (180 mL) [contains sodium benzoate]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F11238882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F11238878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022372s000MedGuide.pdf\" target=\"_blank\">",
"      file://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022372s000MedGuide.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F11239126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Each bottle of oral solution must be diluted prior to use. The entire contents of each bottle should be consumed, followed by each postdose hydration amount. Patients should avoid red and purple liquids, milk, and alcoholic beverages on the day prior and the day of the colonoscopy. Oral medications should not be administered within 1 hour of start of therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Day prior to colonoscopy:",
"     </i>",
"     Patients may have a light breakfast or only clear liquids may be consumed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Day of the colonoscopy:",
"     </i>",
"     Only clear liquids may be consumed.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F11238905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Bowel cleansing prior to GI examination",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F11239038\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Uric acid increased (24%), bicarbonate decreased (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Abdominal distension (40%), abdominal pain (36%), nausea (36%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: Discomfort (54%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Headache (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Hypercalcemia (10%), anion gap increased (9%), osmolality increased (6%), hyponatremia (3%), chloride increased (2%), hyperkalemia (2%), osmolality decreased (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Vomiting (8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hepatic: Bilirubin increased (9%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Renal: BUN increased (2%), creatinine increased (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): AV block, CPK increased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F11238909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to sodium sulfate, potassium sulfate, magnesium sulfate, or any component of the formulation; GI obstruction, bowel perforation, gastric retention, ileus, toxic colitis, toxic megacolon",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F11238910\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Arrhythmias: Serious arrhythmias have occurred rarely with the use of ionic osmotic laxative products; use caution in patients at increased risk for arrhythmias (eg, recent MI, unstable angina, cardiomyopathy, history of prolonged QT, HF); consider baseline and post-colonoscopy ECGs in patients at increased risk for arrhythmias.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Fluid and electrolyte abnormalities: May cause fluid and electrolyte disturbances, particularly in patients at increased risk (eg, renal impairment, concomitant mediations that alter electrolyte balance). Any pre-existing electrolyte abnormalities should be corrected prior to use and patients should be adequately hydrated before, during, and after use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; GI effects: Osmotic laxatives may produce colonic mucosal aphthous ulcerations, including cases of ischemic colitis. Use caution when interpreting colonoscopy results in patients with inflammatory bowel disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Seizures: Seizures associated with electrolyte abnormalities (eg, hyponatremia, hypokalemia) and low serum osmolality have occurred; use with caution in patients with underlying electrolyte disturbances and in patients at increased risk for seizures (eg, concomitant medications that lower seizure threshold, withdrawal from alcohol or benzodiazepines).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Gout: May cause transient increases in uric acid; use caution in patients with gout.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Impaired gag reflex: Observe unconscious or semiconscious patients with impaired gag reflex or those who are otherwise prone to regurgitation or aspiration during administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Renal impairment: Use caution in patients with renal impairment; adequate hydration is particularly important in these patients or in patients receiving concomitant medications that may affect renal function (eg, diuretics, angiotensin converting enzyme inhibitors). Consider baseline and post-colonoscopy electrolyte, creatinine, and BUN levels in patients at increased risk for renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Ulcerative colitis: Use with caution in patients with severe, active ulcerative colitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Appropriate use: Evaluate patients with symptoms of bowel obstruction/perforation (nausea, vomiting, abdominal pain or distension) prior to use. Each bottle must be diluted with water prior to use; inadvertent administration of undiluted solution may increase the risk of nausea, vomiting, and fluid/electrolyte abnormalities.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F11304698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfacalcidol: May increase the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Magnesium Salts may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of oral magnesium salts within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Pamidronate; Zoledronic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcitriol: May increase the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: May enhance the adverse/toxic effect of Magnesium Salts. Magnesium Salts may enhance the hypotensive effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Polystyrene Sulfonate: Laxatives may enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. More specifically, concomitant use of calcium polystyrene sulfonate with magnesium-containing laxatives may result in metabolic alkalosis or with sorbitol may result in intestinal necrosis.  Management: Avoid concomitant use of calcium polystyrene sulfonate (rectal or oral) and magnesium-containing laxatives or sorbitol.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: Magnesium Sulfate may enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferiprone: Magnesium Salts may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: Magnesium Salts may decrease the serum concentration of Eltrombopag.  Management: Separate administration of eltrombopag and any polyvalent cation (e.g., magnesium-containing products) by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Nasal): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Systemic): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mefloquine: May diminish the therapeutic effect of Anticonvulsants. Mefloquine may decrease the serum concentration of Anticonvulsants. Management: Mefloquine is contraindicated for malaria prophylaxis in persons with a history of convulsions.  Monitor anticonvulsant concentrations and treatment response closely with concurrent use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Magnesium Salts may decrease the serum concentration of Mycophenolate.  Management: Separate doses of mycophenolate and oral magnesium salts. Monitor for reduced effects of mycophenolate if taken concomitant with oral magnesium salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents: Magnesium Salts may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Magnesium Salts may decrease the serum concentration of Phosphate Supplements.  Management: Administer oral phosphate supplements at least 1 hour before, or 2 hours after, oral magnesium salt administration.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Potassium Phosphate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Magnesium Salts may decrease the absorption of Quinolone Antibiotics. Of concern only with oral administration of both agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Polystyrene Sulfonate: Laxatives may enhance the adverse/toxic effect of Sodium Polystyrene Sulfonate. More specifically, concomitant use of sodium polystyrene sulfonate with magnesium-containing laxatives may result in metabolic alkalosis or with sorbitol may result in intestinal necrosis.  Management: Avoid concomitant use of sodium polystyrene sulfonate (rectal or oral) and magnesium-containing laxatives or sorbitol.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Magnesium Salts may decrease the absorption of Tetracycline Derivatives. Only applicable to oral preparations of each agent.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Magnesium Salts may decrease the serum concentration of Trientine. Trientine may decrease the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F11238906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F11238907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted in animals or in humans. Use with caution in pregnant women.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F11238908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F11239108\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Avoid red and purple liquids, milk, and alcoholic beverages.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F11239133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Consider baseline and postprocedure labwork (eg, electrolytes, BUN, creatinine) in patients at risk for renal impairment, seizure, or who have a history of electrolyte abnormality; ECG (prior to therapy and post-colonoscopy) in patients with risks for prolonged QT or arrhythmias.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F11239109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Induces catharsis by the osmotic effects of the unabsorbed ions in the GI tract",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F11239111\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pharmacokinetics measured in terms of serum sulfate unless otherwise specified.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Sulfate anions poorly absorbed in the GI tract",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability: Systemic exposure increased (AUC and C",
"     <sub>",
"      max",
"     </sub>",
"     by 54% and 44%, respectively) in patients with renal impairment compared to healthy patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life, elimination: ~9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak: ~17 hours after first dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Feces (primarily)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16094 Version 26.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.69.132.100-0D12DA5E94-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38820=[""].join("\n");
var outline_f37_58_38820=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238875\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238904\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11239124\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11239125\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11368444\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238882\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238878\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11239126\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238905\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11239038\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238909\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238910\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300070\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11304698\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238906\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238907\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238908\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11239108\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11239133\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11239109\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11239111\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16094\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16094|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?36/37/37460?source=related_link\">",
"      Sodium, potassium and magnesium sulfates bowel preparation kit: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_58_38821="Flumazenil: Pediatric drug information";
var content_f37_58_38821=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Flumazenil: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?40/6/41062?source=see_link\">",
"    see \"Flumazenil: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/60/36803?source=see_link\">",
"    see \"Flumazenil: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F172027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Romazicon&reg; [DSC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F172028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Anexate&reg;;",
"     </li>",
"     <li>",
"      Flumazenil Injection;",
"     </li>",
"     <li>",
"      Flumazenil Injection, USP;",
"     </li>",
"     <li>",
"      Romazicon&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1052814\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote, Benzodiazepine",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F12674641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepine reversal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Minimal information available; dosing is extrapolated from experiences in pediatric patients 1-17 years; Initial dose: 0.01 mg/kg given over 15 seconds; may repeat 0.01 mg/kg after 45 seconds, and then every minute to a maximum total cumulative dose of 0.05 mg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Continuous I.V. infusion (as an alternative to repeat bolus doses): 0.005-0.01 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ; dose based on a case report of premature neonate (GA: 32 weeks) exposed to high doses of diazepam intrapartum (Dixon, 1998)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Myoclonus, benzodiazepine-induced: I.V.: 0.0078 mg/kg as a single dose was effective in one full-term neonate who was receiving continuous infusion midazolam (Zaw, 2001)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1052806\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?40/6/41062?source=see_link\">",
"      see \"Flumazenil: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants and Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Benzodiazepine reversal when used in conscious sedation or general anesthesia: Initial dose: 0.01 mg/kg (maximum dose: 0.2 mg) given over 15 seconds; may repeat 0.01 mg/kg (maximum dose: 0.2 mg) after 45 seconds, and then every minute to a maximum total cumulative dose of 0.05 mg/kg or 1 mg, whichever is lower; usual total dose: 0.08-1 mg (mean: 0.65 mg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Management of benzodiazepine overdose: Minimal information available; initial dose: 0.01 mg/kg (maximum dose: 0.2 mg) with repeat doses of 0.01 mg/kg (maximum dose: 0.2 mg) given every minute to a maximum total cumulative dose of 1 mg; as an alternative to repeat bolus doses, follow up continuous infusions of 0.005-0.01 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     have been used; further studies are needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Benzodiazepine reversal when used in conscious sedation or general anesthesia: 0.2 mg given over 15 seconds; may repeat 0.2 mg after 45 seconds and then every 60 seconds up to a total of 1 mg, usual total dose: 0.6-1 mg. In event of resedation, may repeat doses at 20-minute intervals with maximum of 1 mg/dose (given at 0.2 mg/minute); maximum dose: 3 mg in 1 hour.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Management of benzodiazepine overdose: 0.2 mg over 30 seconds; may give 0.3 mg dose after 30 seconds if desired level of consciousness is not obtained; additional doses of 0.5 mg can be given over 30 seconds at 1-minute intervals up to a cumulative dose of 3 mg; usual cumulative dose: 1-3 mg; rarely, patients with partial response at 3 mg may require additional titration up to total dose of 5 mg; if patient has not responded 5 minutes after cumulative dose of 5 mg, the major cause of sedation is not likely due to benzodiazepines. In the event of resedation, may repeat doses at 20-minute intervals with maximum of 1 mg/dose (given at 0.5 mg/minute); maximum dose: 3 mg in 1 hour.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     Initial dose: Use normal dose; repeat doses should be decreased in size or frequency",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F172006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 0.1 mg/mL (5 mL, 10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Romazicon&reg;: 0.1 mg/mL (10 mL [DSC]) [contains edetate disodium]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F171991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1052818\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: For I.V. use only; administer by rapid I.V. injection over 15-30 seconds via a freely running I.V. infusion into larger vein (to decrease chance of pain, phlebitis). Children: Do not exceed 0.2 mg/minute. Adults: Repeat doses: Do not exceed 0.2 mg/minute for reversal of general anesthesia and do not exceed 0.5 mg/minute for reversal of benzodiazepine overdose.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F172078\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR, NS.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1052809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 25&deg;C (77&deg;F); compatible with D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR, or NS for 24 hours; discard any unused solution after 24 hours",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1052817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Benzodiazepine antagonist; reverses sedative effects of benzodiazepines used in general anesthesia or conscious sedation; management of benzodiazepine overdose;",
"     <b>",
"      not indicated",
"     </b>",
"     for ethanol, barbiturate, general anesthetic or narcotic overdose",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F7914344\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Flumazenil may be confused with influenza virus vaccine",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F172077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Flushing, palpitation, vasodilation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Abnormal crying, agitation, anxiety, ataxia, depersonalization, depression, dizziness, dysphoria, emotional lability, euphoria, fatigue, headache, insomnia, malaise, nervousness, paranoia, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hot flashes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local:  Injection site reaction, pain at injection site, rash, skin abnormality, thrombophlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Hypoesthesia, paresthesia, weakness, tremor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Abnormal vision, blurred vision, lacrimation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea, hyperventilation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Abnormal hearing, altered blood pressure increased/decreased, arrhythmia, bradycardia, chest pain, confusion, coldness sensation, delirium, difficulty concentrating, dysphonia, fear, generalized seizure, hiccups, hyperacusis, hypertension, junctional tachycardia, panic attacks, rigors, seizure, shivering, somnolence, stupor, tachycardia, thick tongue, tinnitus, transient hearing impairment, ventricular tachycardia, withdrawal syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1052822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to flumazenil, any component, or benzodiazepines; patients given benzodiazepines for control of potentially life-threatening conditions (eg, control of intracranial pressure or status epilepticus); patients with signs of serious cyclic-antidepressant overdosage",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1052805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Resedation may occur with flumazenil use (due to its short half-life in comparison to some benzodiazepines); pediatric patients (especially 1-5 years of age) may experience resedation; these patients may require repeat bolus doses or continuous infusion; monitor patients for return of sedation, respiratory depression, and other residual benzodiazepine effects. Flumazenil should be used with caution in the intensive care unit because of increased risk of unrecognized benzodiazepine dependence in such settings. Flumazenil may provoke panic attacks in patients with panic disorder. Do not use flumazenil until effects of neuromuscular blockers have been fully reversed. Use with caution in patients with liver disease and decrease the amount or frequency of repeat doses. Use with caution in patients with head injury due to possibility of precipitating convulsions or altering blood flow in patients receiving benzodiazepines. Use with caution in patients with alcoholism and other drug dependencies; these patients may also be dependent on benzodiazepines. Clinicians should not rely on flumazenil to reverse respiratory depression/hypoventilation; flumazenil is not a substitute for evaluation of oxygenation; establishing an airway and assisting ventilation, as necessary, is always the initial step in overdose management. Safety and efficacy of flumazenil have not been established in children &lt;1 year of age.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1052804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Flumazenil may precipitate seizures in high risk patients",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; possible risk factors for seizures include patients physically dependent on benzodiazepines, patients treated with benzodiazepines for seizure disorders or other reasons, patients who received recent repeated doses of parenteral benzodiazepines, overdose patients with seizure activity prior to flumazenil, patients with serious cyclic antidepressant or mixed drug overdoses, patients with concurrent major sedative-hypnotic drug withdrawal, and patients with severe hepatic impairment. Higher than normal doses of benzodiazepines may be required to treat these seizures. Mixed drug overdose patients who have ingested drugs that increase the likelihood of seizures (eg, cocaine, lithium, cyclosporine, cyclic antidepressants, bupropion, methylxanthines, MAO inhibitors, isoniazid, or propoxyphene) are at extremely high risk for seizures (flumazenil may be contraindicated in these patients). Flumazenil is not recommended in epileptic patients receiving chronic benzodiazepine therapy or in cases of serious cyclic antidepressant overdoses. Dosage of flumazenil should be individualized; clinicians should be prepared to manage seizure activity.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299345\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F172000\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypnotics (Nonbenzodiazepine): Flumazenil may diminish the sedative effect of Hypnotics (Nonbenzodiazepine).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ramelteon.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F172002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F172014\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not seen in animal reproduction studies. Embryocidal effects were seen at large doses. Use during labor and delivery is not recommended. In general, medications used as antidotes should take into consideration the health and prognosis of the mother (Bailey, 2003).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1052813\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Level of consciousness and resedation, blood pressure, heart rate, respiratory rate, continuous pulse oximetry; monitor for resedation for 1-2 hours after reversal of sedation in patients who receive benzodiazepine sedation",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1052803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antagonizes the effect of benzodiazepines on the GABA/benzodiazepine receptor complex. Flumazenil is benzodiazepine specific and does not antagonize other nonbenzodiazepine GABA agonists (including ethanol, barbiturates, general anesthetics); does not reverse the effects of opiates.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1052820\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Benzodiazepine reversal: Within 1-3 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: 6-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Usually &lt;1 hour; duration is related to dose given and benzodiazepine plasma concentrations; reversal effects of flumazenil may wear off before effects of benzodiazepine and resedation may occur",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1052821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Follows a two compartment open model;",
"     <b>",
"      Note:",
"     </b>",
"     Clearance and V",
"     <sub>",
"      d",
"     </sub>",
"     per kg are similar for children and adults, but children display more variability",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Distributes extensively in the extravascular space; Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Initial V",
"     <sub>",
"      d",
"     </sub>",
"     : 0.5 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     V",
"     <sub>",
"      dss",
"     </sub>",
"     : 0.9-1.1 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &sim;50%; primarily to albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In the liver to the de-ethylated free acid and its glucuronide conjugate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: Terminal: 20-75 minutes (mean: 40 minutes)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Alpha: 4-11 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Terminal: 40-80 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: 99% hepatically eliminated; &lt;1% excreted unchanged in urine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Clearance: Dependent upon hepatic blood flow; Adults: 0.8-1 L/hour/kg",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1052811\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/60/36803?source=see_link\">",
"      see \"Flumazenil: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Flumazenil does not consistently reverse amnesia; do not engage in activities requiring alertness for 24 hours after discharge; resedation may occur in patients on long-acting benzodiazepines (such as diazepam); avoid alcohol or OTC medications for 24 hours after flumazenil is used or if benzodiazepine effects persist; may cause dry mouth",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1052823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Flumazenil is a weak lipophilic base. In one study of conscious sedation reversal in 107 pediatric patients (1-17 years of age), resedation occurred between 19-50 minutes after the start of flumazenil. Flumazenil has been used to successfully treat paradoxical reactions in children associated with midazolam use (eg, agitation, restlessness, combativeness) (Massanari, 1997).",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Baktai G, Szekely E, Marialigeti T, et al, &ldquo;Use of Midazolam (Dormicum) and Flumazenil (Anexate) in Paediatric Bronchology,&rdquo;",
"      <i>",
"       Curr Med Res Opin",
"      </i>",
"      , 1992, 12(9):552-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38821/abstract-text/1582237 /pubmed\" id=\"1582237 \" target=\"_blank\">",
"        1582237",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Clark RF, Sage TA, Tunget C, et al, &ldquo;Delayed Onset Lorazepam Poisoning Successfully Reversed By Flumazenil in a Child: Case Report and Review of the Literature,&rdquo;",
"      <i>",
"       Pediatr Emerg Care",
"      </i>",
"      , 1995, 11(1):32-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38821/abstract-text/7739960/pubmed\" id=\"7739960\" target=\"_blank\">",
"        7739960",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dixon JC, Speidel BD, and Dixon JJ, \"Neonatal Flumazenil Therapy Reverses Maternal Diazepam,\"",
"      <i>",
"       Acta Paediatr",
"      </i>",
"      , 1998, 87(2):225-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38821/abstract-text/9512213/pubmed\" id=\"9512213\" target=\"_blank\">",
"        9512213",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jones RD, Lawson AD, Andrew LJ, et al, &ldquo;Antagonism of the Hypnotic Effect of Midazolam in Children: A Randomized, Double Blind Study of Placebo and Flumazenil Administered After Midazolam-Induced Anaesthesia,&rdquo;",
"      <i>",
"       Br J Anaesth",
"      </i>",
"      , 1991, 66(6):660-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38821/abstract-text/2064881/pubmed\" id=\"2064881\" target=\"_blank\">",
"        2064881",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Massanari M, Novitsky J, and Reinstein LJ, &ldquo;Paradoxical Reactions in Children Associated With Midazolam Use During Endoscopy,&rdquo;",
"      <i>",
"       Clin Pediatr",
"      </i>",
"      , 1997, 36(12):681-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38821/abstract-text/9415834/pubmed\" id=\"9415834\" target=\"_blank\">",
"        9415834",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Richard P, Autret E, Bardol J, et al, &ldquo;The Use of Flumazenil in a Neonate,&rdquo;",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 1991, 29(1):137-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38821/abstract-text/2005661/pubmed\" id=\"2005661\" target=\"_blank\">",
"        2005661",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Roald OK and Dahl V, &ldquo;Flunitrazepam Intoxication in a Child Successfully Treated With the Benzodiazepine Antagonist Flumazenil,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 1989, 17(12):1355-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38821/abstract-text/2512053/pubmed\" id=\"2512053\" target=\"_blank\">",
"        2512053",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shannon M, Albers G, Burkhart K, et al, &ldquo;Safety and Efficacy of Flumazenil in the Reversal of Benzodiazepine-Induced Conscious Sedation. The Flumazenil Pediatric Study Group,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1997, 131(4):582-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38821/abstract-text/9386663/pubmed\" id=\"9386663\" target=\"_blank\">",
"        9386663",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sugarman JM and Paul RI, &ldquo;Flumazenil: A Review,&rdquo;",
"      <i>",
"       Pediatr Emerg Care",
"      </i>",
"      , 1994, 10(1):37-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38821/abstract-text/8177806/pubmed\" id=\"8177806\" target=\"_blank\">",
"        8177806",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zaw W, Knoppert DC, and da Silva O, \"Flumazenil's Reversal of Myoclonic-Like Movements Associated With Midazolam in Term Newborns,\"",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2001, 21(5):642-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38821/abstract-text/11349753/pubmed\" id=\"11349753\" target=\"_blank\">",
"        11349753",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13307 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-221.10.40.232-E5FD8A8851-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38821=[""].join("\n");
var outline_f37_58_38821=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708776\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F172027\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F172028\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052814\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12674641\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052806\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F172006\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171991\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052818\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F172078\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052809\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052817\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7914344\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F172077\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052822\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052805\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052804\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299345\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F172000\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F172002\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F172014\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052813\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052803\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052820\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052821\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052811\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052823\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13307\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13307|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?40/6/41062?source=related_link\">",
"      Flumazenil: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/60/36803?source=related_link\">",
"      Flumazenil: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_58_38822="Serum tumor markers in testicular germ cell tumors";
var content_f37_58_38822=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Serum tumor markers in testicular germ cell tumors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/58/38822/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/58/38822/contributors\">",
"     M Dror Michaelson, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/58/38822/contributors\">",
"     William K Oh, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/58/38822/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/58/38822/contributors\">",
"     Philip W Kantoff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/58/38822/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/58/38822/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/58/38822/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular cancers germ cell tumors (GCTs) have become one of the most curable solid neoplasms, due to remarkable treatment advances that began in the late 1970s. Prior to that time, testicular cancer accounted for 11 percent of cancer deaths in men between the ages of 25 to 34, and the five-year survival rate was 64 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/1\">",
"     1",
"    </a>",
"    ]. Currently, the five-year survival rate is over 95 percent, largely due to better understanding of the natural history of testicular tumors, improved staging and surgical techniques, the use of effective platinum-based combination chemotherapy, and the availability of highly sensitive serum tumor markers to detect minimal residual disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13432?source=see_link\">",
"     \"Overview of the treatment of testicular germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Three serum tumor markers have established roles in the management of men with testicular germ cell tumors:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The beta subunit of human chorionic gonadotropin (&beta;-hCG)",
"     </li>",
"     <li>",
"      Alpha fetoprotein (AFP)",
"     </li>",
"     <li>",
"      Lactate dehydrogenase (LDH)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Serum concentrations of AFP",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    &beta;-hCG are elevated in 80 to 85 percent of men with nonseminomatous germ cell tumors (NSGCTs). In contrast, serum &beta;-hCG is elevated in fewer than 25 percent of seminomas, and AFP is not elevated in pure seminomas (",
"    <a class=\"graphic graphic_table graphicRef81626 \" href=\"mobipreview.htm?43/42/44715\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Although these markers can provide supportive evidence for the initial diagnosis of a testicular cancer and are useful for prognosis and risk stratification, their main utility is for monitoring response to treatment and detecting recurrence. The role of these serum tumor markers in the management of men with testicular germ cell tumors (GCTs) will be reviewed here. The integration of serum tumor markers into the overall follow-up plan for patients who have completed their initial treatment for a germ cell tumor is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/45/9943?source=see_link\">",
"     \"Posttreatment follow-up for men with testicular germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HUMAN CHORIONIC GONADOTROPIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular GCTs produce the intact hCG molecule. However, serum assays measure the beta subunit, since the alpha subunit is common to several pituitary hormones. &beta;-hCG is the most commonly elevated tumor marker in testicular cancer. The normal value in men is less than 5 to 10",
"    <span class=\"nowrap\">",
"     IU/L.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Nonseminomatous germ cell tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    production of hCG by testicular NSGCTs varies depending upon the tumor burden and on the histologic subtypes. Serum levels of &beta;-hCG are elevated in 10 to 20 percent of clinical stage I NSGCTs and up to 40 percent of those with advanced disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]. Serum hCG elevations are typically seen in tumors that are comprised of pure or mixed embryonal carcinoma or choriocarcinoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Seminomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with pure seminomas, an elevated serum &beta;-hCG is seen in 15 to 20 percent of those with advanced disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]. An increase in serum &beta;-hCG primarily reflects higher tumor burden but not necessarily a greater metastatic potential [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/3\">",
"     3",
"    </a>",
"    ]. Thus, an elevated serum &beta;-hCG that returns to normal after orchiectomy in a patient with stage I seminoma does not indicate advanced disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/2/22567?source=see_link\">",
"     \"Treatment of stage I seminoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Half-life",
"    </span>",
"    &nbsp;&mdash;&nbsp;The serum half-life of &beta;-hCG is 1.5 to 3 days, which is an important consideration in determining the response to therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]. Rapid normalization after orchiectomy for stage I disease suggests elimination of the tumor, while persistence of an increased &beta;-hCG level after treatment may be the only evidence of occult disease (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Monitoring response to therapy'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     False-positive results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although persistent elevation in serum &beta;-hCG implies the presence of residual disease, it should be interpreted with caution, since false-positive elevation of hCG can be due to a number of factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypogonadal states lead to a compensatory increase in pituitary production of hCG as well as the secretion of luteinizing hormone, which crossreacts with the immunoassay used to measure &beta;-hCG. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12824?source=see_link\">",
"       \"Clinical features and diagnosis of male hypogonadism\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/18/8488?source=see_link\">",
"       \"Causes of secondary hypogonadism in males\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tumor lysis can result in a transient release of hCG during the first cycle of chemotherapy.",
"     </li>",
"     <li>",
"      Presence of heterophile antibodies or other factors can interfere with the immunoassay for &beta;-hCG.",
"     </li>",
"     <li>",
"      Marijuana use has been reported to result in a false-positive elevation of &beta;-hCG in at least one report [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/4\">",
"       4",
"      </a>",
"      ], but this has not been observed in a more extensive series [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other cancers have been associated with elevations in serum &beta;-hCG levels, including neuroendocrine, bladder, kidney, lung, head and neck, gastrointestinal, cervix, uterus and vulvar cancers, lymphoma, and leukemia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Marked elevations (above 10,000",
"    <span class=\"nowrap\">",
"     IU/L)",
"    </span>",
"    in serum &beta;-hCG concentrations occur only in GCTs, the rare patient with trophoblastic differentiation of a primary lung or gastric cancer, or pregnancy or gestational trophoblastic disease in women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hyperthyroidism and hCG",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical hyperthyroidism can develop in men with NSGCTs who have markedly elevated serum &beta;-hCG levels due to ligand-receptor crossreactivity between hCG and thyroid stimulating hormone. The frequency of this complication was illustrated by a series of 144 patients with germ cell tumors, in which five cases (3.5 percent) of hyperthyroidism were identified. All were in patients with markedly elevated &beta;-hCG levels (ie, &gt;50,000",
"    <span class=\"nowrap\">",
"     IU/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/6\">",
"     6",
"    </a>",
"    ]. The symptoms and biochemical evidence of hyperthyroidism abated with treatment of the GCT. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/0/4103?source=see_link&amp;anchor=H8#H8\">",
"     \"Disorders that cause hyperthyroidism\", section on 'Trophoblastic disease and germ cell tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ALPHA FETOPROTEIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alpha fetoprotein (AFP) is normally produced by the fetal yolk sac and other organs, and is essentially undetectable in the serum in normal men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]. The upper limit of normal for serum AFP is less than 10-15",
"    <span class=\"nowrap\">",
"     microg/L.",
"    </span>",
"   </p>",
"   <p>",
"    Many",
"    tissues regain the ability to produce this oncofetal protein if they undergo malignant degeneration; however, serum AFP concentrations above 10,000",
"    <span class=\"nowrap\">",
"     microg/L",
"    </span>",
"    are found almost exclusively in patients with NSGCTs or hepatocellular carcinoma. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Diagnosis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/10/34986?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical features and diagnosis of primary hepatocellular carcinoma\", section on 'Alpha-fetoprotein'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Nonseminomatous germ cell tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;In men with NSGCTs, AFP is produced by yolk sac (endodermal sinus) tumors and, less often, embryonal carcinomas. As with &beta;-hCG, the frequency of an elevated serum AFP increases with advancing clinical stage, from 10 to 20 percent in men with stage I tumors, to 40 to 60 percent of those with disseminated NSGCTs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Seminomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;By definition, pure seminomas do not cause an elevated serum AFP. However, molecular studies have demonstrated AFP mRNA in minute quantities in pure seminoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/7\">",
"     7",
"    </a>",
"    ] and several case reports have described pure seminoma with borderline elevations in serum AFP (10.4 to 16",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/8\">",
"     8",
"    </a>",
"    ]. Higher serum AFP concentrations are considered diagnostic of a nonseminomatous component of the tumor (especially yolk sac elements) or hepatic metastases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/9\">",
"     9",
"    </a>",
"    ]. If the presence of an elevated serum AFP is confirmed, patients should be treated as if they had an NSGCT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Half-life of AFP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The half-life of AFP is approximately five to seven days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]. Following effective therapy, normalization of the serum AFP concentration over 25 to 30 days is indicative of an appropriate decline (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Monitoring response to therapy'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     False-positive AFP",
"    </span>",
"    &nbsp;&mdash;&nbsp;False positive elevations of serum AFP can occur from tumors of the gastrointestinal tract, particularly hepatocellular carcinoma, or from liver damage (eg, cirrhosis, hepatitis, or drug or alcohol abuse) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]. Lysis of tumor cells during the initiation of chemotherapy may result in a transient increase in serum AFP. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/10/34986?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical features and diagnosis of primary hepatocellular carcinoma\", section on 'Alpha-fetoprotein'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     LACTATE DEHYDROGENASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum LDH concentrations are elevated in 40 to 60 percent of men with testicular GCTs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]. LDH is a less sensitive and less specific tumor marker than &beta;-hCG or AFP for men with NSGCTs, but it may be the only marker that is elevated in some seminomas. The degree of elevation in the serum LDH has prognostic value in men with advanced GCTs and is incorporated into the International Germ Cell Cancer Collaborative Group (IGCCCG) risk stratification system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Prognostic value and risk stratification'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/17/24852?source=see_link&amp;anchor=H2#H2\">",
"     \"Risk stratification of metastatic testicular germ cell tumors\", section on 'IGCCCG staging system'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serum LDH can be elevated due to a variety of processes that result in tissue injury, and thus serum LDH is neither a sensitive nor specific indicator of disease recurrence in men with GCTs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H967899614\">",
"    <span class=\"h1\">",
"     CLINICAL APPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum tumor markers (&beta;-hCG, AFP, LDH) have a potential role in the diagnosis of men with a suspected testicular GCT, in determining the optimal therapy based upon risk stratification, in assessing the response to treatment, and in surveillance following treatment. Serum tumor markers should not be used to screen asymptomatic men for testicular tumors. The literature supporting the utilization of serum tumor markers for these indications has been reviewed in guidelines from the American Society of Clinical Oncology (ASCO) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum levels of &beta;-hCG and AFP should be measured prior to orchiectomy to help establish the diagnosis and to provide guidance for postorchiectomy management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]. The majority of men with a suspected testicular GCT undergo diagnostic orchiectomy for both histologic confirmation and local tumor control. Generally, neither serum &beta;-hCG nor AFP is sufficiently sensitive or specific to establish the diagnosis of testicular cancer in the absence of histologic confirmation. Markedly elevated serum tumor markers can be used to support a presumptive diagnosis of GCT if a biopsy is not feasible because of an urgent need to initiate treatment. Serum tumor markers may also be used to support the diagnosis of GCT if biopsy reveals a poorly differentiated carcinoma without characteristic histopathologic features. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10058?source=see_link\">",
"     \"Extragonadal germ cell tumors involving the mediastinum and retroperitoneum\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/56/9096?source=see_link&amp;anchor=H1568145737#H1568145737\">",
"     \"Poorly differentiated cancer from an unknown primary site\", section on 'Extragonadal germ cell tumors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/56/9096?source=see_link&amp;anchor=H2#H2\">",
"     \"Poorly differentiated cancer from an unknown primary site\", section on 'Diagnostic evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Prognostic value and risk stratification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pretreatment tumor marker levels (&beta;-hCG, AFP, LDH) are valuable for staging and prognosis in men with testicular germ cell tumors. Traditional",
"    <span class=\"nowrap\">",
"     tumor/node/metastasis",
"    </span>",
"    (TNM) staging is not as useful a prognostic tool as in other solid malignancies, because even men with disseminated disease have a high likelihood of long term survival. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41720?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of testicular germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The International Germ Cell Cancer Collaborative Group (IGCCCG) has incorporated serum tumor markers as prognostic indicators in GCTs (",
"    <a class=\"graphic graphic_table graphicRef82117 \" href=\"mobipreview.htm?35/13/36061\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef56341 \" href=\"mobipreview.htm?20/34/21037\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In the IGCCCG schema, pretreatment levels of serum &beta;-hCG, AFP, and LDH are used as independent predictors of risk, along with the site of primary disease and the presence of nonpulmonary visceral metastases (",
"    <a class=\"graphic graphic_table graphicRef61906 \" href=\"mobipreview.htm?41/46/42732\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/11\">",
"     11",
"    </a>",
"    ]. The IGCCCG risk stratification system is described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/17/24852?source=see_link&amp;anchor=H2#H2\">",
"     \"Risk stratification of metastatic testicular germ cell tumors\", section on 'IGCCCG staging system'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Monitoring response to therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serial measurements of serum tumor markers, especially &beta;-hCG and AFP, are used to monitor the response to treatment of GCTs, with the fall in marker values signifying an adequate tumor response, and a plateau or rise in marker levels indicating relapse or resistance to therapy. Assessment of response to therapy (orchiectomy for localized disease, systemic therapy for advanced disease) requires a consideration of the serum half-lives of hCG and AFP. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Half-life'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H11\">",
"     'Half-life of AFP'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Guidelines from the American Society of Clinical Oncology (ASCO) have outlined recommendations for the use of serum tumor markers in men being treated for testicular germ cell tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1040489794\">",
"    <span class=\"h3\">",
"     NSGCT patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Considerations in the use of serum tumor markers following orchiectomy in patients with NSGCT include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Following orchiectomy, &beta;-hCG and AFP should be measured prior to chemotherapy. The presence of an elevation in either marker that does not resolve in a manner that is consistent with the tumor marker&rsquo;s half-life signifies the presence of residual disease, even if there is no other evidence of residual disease. The level of the serum markers is also useful in risk stratification and determining the duration of treatment required. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/17/24852?source=see_link&amp;anchor=H2#H2\">",
"       \"Risk stratification of metastatic testicular germ cell tumors\", section on 'IGCCCG staging system'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13432?source=see_link\">",
"       \"Overview of the treatment of testicular germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with clinical stage I or II disease in whom retroperitoneal lymphadenectomy is being considered, the presence of increasing levels of &beta;-hCG or AFP indicates the need for systemic therapy similar to that in patients with stage III disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/19/10550?source=see_link\">",
"       \"Management of stage II nonseminomatous germ cell tumors\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/29/26070?source=see_link\">",
"       \"Management of stage I nonseminomatous germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients receiving chemotherapy either as an adjuvant or for advanced disease, &beta;-hCG and AFP should be measured prior to each treatment cycle and upon completion of chemotherapy to assess response to therapy and for evidence of relapse or resistance to treatment. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/63/24568?source=see_link\">",
"       \"Initial risk-stratified treatment for advanced testicular germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      After completion of definitive therapy (orchiectomy, with or without chemotherapy), &beta;-hCG and AFP should be measured at each follow-up visit. Elevation in serum tumor markers may provide the first evidence of relapse and this approach allows initiation of salvage therapy while the tumor burden is relatively small. The frequency and duration of post-treatment follow-up are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/45/9943?source=see_link\">",
"       \"Posttreatment follow-up for men with testicular germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1040489802\">",
"    <span class=\"h3\">",
"     Seminoma patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Considerations in the use of serum tumor markers following orchiectomy in patients with pure testicular seminoma include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who had an elevation in either serum &beta;-hCG or LDH prior to orchiectomy, these markers should be repeated following orchiectomy. If postoperative therapy (chemotherapy or radiation therapy) is required, serum tumor markers should be repeated upon completion of that therapy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/2/22567?source=see_link\">",
"       \"Treatment of stage I seminoma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/45/22230?source=see_link\">",
"       \"Treatment of stage II seminoma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/63/24568?source=see_link\">",
"       \"Initial risk-stratified treatment for advanced testicular germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      After completion of definitive therapy (orchiectomy with or without further treatment), &beta;-hCG and LDH should be measured at each follow-up visit. Elevation in serum tumor markers may provide the first evidence of relapse and this approach allows initiation of salvage therapy while the tumor burden is relatively small. The frequency and duration of post-treatment follow-up are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/45/9943?source=see_link\">",
"       \"Posttreatment follow-up for men with testicular germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H165070\">",
"    <span class=\"h1\">",
"     EXTRAGONADAL GCTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum &beta;-hCG and AFP levels are also frequently elevated in patients with retroperitoneal and mediastinal GCTs. The role of tumor markers in these patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10058?source=see_link&amp;anchor=H4#H4\">",
"     \"Extragonadal germ cell tumors involving the mediastinum and retroperitoneum\", section on 'Tumor markers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum levels of the beta subunit of human chorionic gonadotropin (&beta;-hCG), alpha fetoprotein (AFP) and lactate dehydrogenase (LDH) are reliable markers for the presence of testicular germ cell tumors (GCTs).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      &Beta;-hCG is produced by embryonal carcinoma and choriocarcinoma and is the most commonly elevated tumor marker in patients with nonseminomatous GCTs. &Beta;-hCG is also elevated in 15 to 25 percent of patients with seminomas. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Human chorionic gonadotropin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      AFP is absent in the serum of normal adults but is detectable in patients with nonseminomatous GCTs and hepatocellular carcinoma. AFP is not elevated in patients with pure seminomas. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Alpha fetoprotein'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      LDH is a less sensitive and less specific tumor marker than &beta;-hCG or AFP for men with NSGCTs, but is elevated in 40 to 60 percent of men with testicular GCTs.",
"     </li>",
"     <li>",
"      The extent of elevation of these tumor markers is an important prognostic marker for patients with GCTs, and this information is incorporated into the International Germ Cell Cancer Collaborative Group (IGCCCG) risk stratification system and the Tumor Node Metastasis (TNM) staging system (",
"      <a class=\"graphic graphic_table graphicRef81626 \" href=\"mobipreview.htm?43/42/44715\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef82117 \" href=\"mobipreview.htm?35/13/36061\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef56341 \" href=\"mobipreview.htm?20/34/21037\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Prognostic value and risk stratification'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41720?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and staging of testicular germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Serum tumor markers should be measured prior to orchiectomy and following orchiectomy prior to any planned systemic therapy. Tumor markers should then be monitored during any additional therapy, to document the adequacy of treatment. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Monitoring response to therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serum tumor markers should be measured regularly following treatment to detect any evidence of residual or recurrent disease. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/45/9943?source=see_link\">",
"       \"Posttreatment follow-up for men with testicular germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38822/abstract/1\">",
"      Einhorn LH. Treatment of testicular cancer: a new and improved model. J Clin Oncol 1990; 8:1777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38822/abstract/2\">",
"      Gilligan TD, Seidenfeld J, Basch EM, et al. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol 2010; 28:3388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38822/abstract/3\">",
"      Hori K, Uematsu K, Yasoshima H, et al. Testicular seminoma with human chorionic gonadotropin production. Pathol Int 1997; 47:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38822/abstract/4\">",
"      Garnick MB. Spurious rise in human chorionic gonadotropin induced by marihuana in patients with testicular cancer. N Engl J Med 1980; 303:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38822/abstract/5\">",
"      Braunstein GD, Thompson R, Gross S, Soares JR. Marijuana use does not spuriously elevate serum human chorionic gonadotropin levels. Urology 1985; 25:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38822/abstract/6\">",
"      Oosting SF, de Haas EC, Links TP, et al. Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors. Ann Oncol 2010; 21:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38822/abstract/7\">",
"      Yuasa T, Yoshiki T, Ogawa O, et al. Detection of alpha-fetoprotein mRNA in seminoma. J Androl 1999; 20:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38822/abstract/8\">",
"      Nazeer T, Ro JY, Amato RJ, et al. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases. Oncol Rep 1998; 5:1425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38822/abstract/9\">",
"      Javadpour N. Significance of elevated serum alphafetoprotein (AFP) in seminoma. Cancer 1980; 45:2166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38822/abstract/10\">",
"      Mencel PJ, Motzer RJ, Mazumdar M, et al. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol 1994; 12:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/58/38822/abstract/11\">",
"      International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15:594.",
"     </a>",
"    </li>",
"    <li>",
"     AJCC Cancer Staging Manual, 5th, Fleming ID, Cooper JS, Henson DE, et al (Eds), Lippincott-Raven, New York 1997.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2995 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-110.137.129.113-2110654F66-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38822=[""].join("\n");
var outline_f37_58_38822=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HUMAN CHORIONIC GONADOTROPIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Nonseminomatous germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Seminomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Half-life",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      False-positive results",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hyperthyroidism and hCG",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ALPHA FETOPROTEIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Nonseminomatous germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Seminomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Half-life of AFP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      False-positive AFP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      LACTATE DEHYDROGENASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H967899614\">",
"      CLINICAL APPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Prognostic value and risk stratification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Monitoring response to therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1040489794\">",
"      - NSGCT patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1040489802\">",
"      - Seminoma patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H165070\">",
"      EXTRAGONADAL GCTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2995\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2995|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/42/44715\" title=\"table 1\">",
"      Testicular tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/13/36061\" title=\"table 2\">",
"      TNM staging testicular CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?20/34/21037\" title=\"table 3\">",
"      Stage group testicular CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/46/42732\" title=\"table 4\">",
"      Risk strat system advancted TGCTs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/18/8488?source=related_link\">",
"      Causes of secondary hypogonadism in males",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12824?source=related_link\">",
"      Clinical features and diagnosis of male hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/10/34986?source=related_link\">",
"      Clinical features and diagnosis of primary hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41720?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/0/4103?source=related_link\">",
"      Disorders that cause hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10058?source=related_link\">",
"      Extragonadal germ cell tumors involving the mediastinum and retroperitoneum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/63/24568?source=related_link\">",
"      Initial risk-stratified treatment for advanced testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/29/26070?source=related_link\">",
"      Management of stage I nonseminomatous germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/19/10550?source=related_link\">",
"      Management of stage II nonseminomatous germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13432?source=related_link\">",
"      Overview of the treatment of testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/56/9096?source=related_link\">",
"      Poorly differentiated cancer from an unknown primary site",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/45/9943?source=related_link\">",
"      Posttreatment follow-up for men with testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/17/24852?source=related_link\">",
"      Risk stratification of metastatic testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/2/22567?source=related_link\">",
"      Treatment of stage I seminoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/45/22230?source=related_link\">",
"      Treatment of stage II seminoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_58_38823="Estradiol and norethindrone: Drug information";
var content_f37_58_38823=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Estradiol and norethindrone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?0/7/113?source=see_link\">",
"    see \"Estradiol and norethindrone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708751\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F167186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Activella&reg;;",
"     </li>",
"     <li>",
"      CombiPatch&reg;;",
"     </li>",
"     <li>",
"      Mimvey&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F167187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Estalis-Sequi&reg;;",
"     </li>",
"     <li>",
"      Estalis&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F167201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Estrogen and Progestin Combination",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F167188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Patients should be treated with the lowest effective dose and for the shortest duration, consistent with treatment goals.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypoestrogenism:",
"     </b>",
"     Transdermal (patch):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Continuous combined regimen: Apply one patch twice weekly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Continuous sequential regimen: Apply estradiol-only patch for first 14 days of cycle, followed by one CombiPatch&reg; applied twice weekly for the remaining 14 days of a 28-day cycle.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Osteoporosis, prevention in postmenopausal females (Activella&reg;):",
"     </b>",
"     Oral: 1 tablet daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Menopause (moderate-to-severe vasomotor symptoms); vulvar and vaginal atrophy:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Oral (Activella&reg;):",
"     </i>",
"     1 tablet daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Transdermal (patch):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Continuous combined regimen: Apply one patch twice weekly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Continuous sequential regimen: Apply estradiol-only patch for first 14 days of cycle, followed by one CombiPatch&reg; applied twice weekly for the remaining 14 days of a 28-day cycle.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Transdermal patch, combination pack (product-specific dosing for Canadian formulation):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Estalis&reg;: Continuous combined regimen: Apply a new patch twice weekly during a 28-day cycle",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Estalis-Sequi&reg;: Continuous sequential regimen: Apply estradiol-only patch (Vivelle&reg;) for first 14 days, followed by one Estalis&reg; patch applied twice weekly during the last 14 days of a 28-day cycle",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     In women previously receiving oral estrogens, initiate upon reappearance of menopausal symptoms following discontinuation of oral therapy.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F167189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15837941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling (has not been studied); use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15837942\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling (has not been studied); use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F167170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Patch, transdermal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CombiPatch&reg;:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     0.05/0.14: Estradiol 0.05 mg and norethindrone acetate 0.14 mg per day (8s) [9 sq cm]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     0.05/0.25: Estradiol 0.05 mg and norethindrone acetate 0.25 mg per day (8s) [16 sq cm]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 0.5/0.1: Estradiol 0.5 mg and norethindrone acetate 0.1 mg (28s); 1/0.5: Estradiol 1 mg and norethindrone acetate 0.5 mg (28s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Activella&reg;: 0.5/0.1: Estradiol 0.5 mg and norethindrone acetate 0.1 mg (28s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Activella&reg;: 1/0.5: Estradiol 1 mg and norethindrone acetate 0.5 mg (28s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mimvey&trade;: 1/0.5: Estradiol 1 mg and norethindrone acetate 0.5 mg (28s)",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F10241398\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Combination pack:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Estalis-Sequi&reg; 140/50:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patch, transdermal (Vivelle&reg;): Estradiol 50 mcg per day (4s) [14.5 sq cm; total estradiol 4.33 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patch, transdermal (Estalis&reg;): Norethindrone acetate 140 mcg and estradiol 50 mcg per day (4s) [9 sq cm; total norethindrone acetate 2.7 mg, total estradiol 0.62 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Estalis-Sequi&reg; 250/50:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patch, transdermal (Vivelle&reg;): Estradiol 50 mcg per day (4s) [14.5 sq cm; total estradiol 4.33 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patch, transdermal (Estalis&reg;): Norethindrone acetate 250 mcg and estradiol 50 mcg per day (4s) [16 sq cm; total norethindrone acetate 4.8 mg, total estradiol 0.51 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Patch, transdermal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Estalis&reg;;",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     140/50: Norethindrone acetate 140 mcg and estradiol 50 mcg per day (8s) [9 sq cm; total norethindrone acetate 2.7 mg, total estradiol 0.62 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     250/50 Norethindrone acetate 250 mcg and estradiol 50 mcg per day (8s) [16 sq cm; total norethindrone acetate 4.8 mg, total estradiol 0.51 mg]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F167158\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Tablet",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F167172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Transdermal patch: Apply to clean dry skin. Do not apply transdermal patch to breasts; apply to lower abdomen, avoiding waistline. Rotate application sites. Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F167171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Women with an intact uterus:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet: Treatment of moderate-to-severe vasomotor symptoms associated with menopause; treatment of vulvar and vaginal atrophy; prophylaxis for postmenopausal osteoporosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Transdermal patch: Treatment of moderate-to-severe vasomotor symptoms associated with menopause; treatment of vulvar and vaginal atrophy; treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F167199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Altered blood pressure, cardiovascular accident, edema, MI, stroke, venous thromboembolism, thrombophlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dementia, dizziness, emotional lability, fatigue, headache, insomnia, irritability, mental depression, migraine, mood changes, nervousness, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Chloasma, erythema multiforme, erythema nodosum, hemorrhagic eruption, hirsutism, itching, loss of scalp hair, melasma, pruritus, seborrhea, skin rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Breast cancer, breast enlargement, breast tenderness, breast pain, fibrocystic breast changes, galactorrhea, hypocalcemia, libido changes, nipple discharge, triglycerides increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, bloating, changes in appetite, cramps, flatulence, gallbladder disease, gastroenteritis, nausea, pancreatitis, vomiting, weight gain/loss",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Alterations in frequency and flow of menses, changes in cervical secretions, cystitis-like syndrome, endometrial cancer, endometrial hyperplasia, endometrial thickening, endometriosis exacerbation, genital moniliasis, ovarian cancer, ovarian cyst, postmenopausal bleeding, premenstrual-like syndrome, size of uterine leiomyomata increased, uterine fibroid, vaginal candidiasis, vaginal hemorrhage, vaginitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Aggravation of porphyria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Cholestatic jaundice",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Application site reaction (transdermal patch)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, back pain, chorea, extremity pain, leg cramps, myalgia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Contact lens intolerance, corneal curvature steepening, retinal vascular thrombosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Asthma exacerbation, nasopharyngitis, pharyngitis, pulmonary thromboembolism, rhinitis, sinusitis, upper respiratory tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, carbohydrate intolerance, flu-like syndrome, viral infection",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F167175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to estrogens, progestins, or any components; carcinoma of the breast; estrogen-dependent tumor; undiagnosed abnormal vaginal bleeding; history of or current thrombophlebitis or venous thromboembolic disorders (including DVT, PE); active or recent (within 1 year) arterial thromboembolic disease (eg, stroke, MI); hysterectomy; hepatic dysfunction or disease; pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F167161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Breast cancer:",
"     <b>",
"      [U.S. Boxed Warning]: Based on data from the Women&rsquo;s Health Initiative (WHI) studies, an increased risk of invasive breast cancer was observed in postmenopausal women using conjugated estrogens (CE) in combination with medroxyprogesterone acetate (MPA).",
"     </b>",
"     This risk may be associated with duration of use and declines once combined therapy is discontinued (Chlebowski, 2009). The risk of invasive breast cancer was decreased in postmenopausal women with a hysterectomy using CE only, regardless of weight. However, the risk was not significantly decreased in women at high risk for breast cancer (family history of breast cancer, personal history of benign breast disease) (Anderson, 2012).An increase in abnormal mammogram findings has also been reported with estrogen alone or in combination with progestin therapy. Estrogen use may also lead to severe hypercalcemia in patients with breast cancer and bone metastases; discontinue estrogen if hypercalcemia occurs. Use is contraindicated in patients with known or suspected breast cancer.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dementia:",
"     <b>",
"      [U.S. Boxed Warning]: Estrogens with or without progestin should not be used to prevent dementia. In the Women&rsquo;s Health Initiative Memory Study (WHIMS), an increased incidence of dementia was observed in women &ge;65 years of age taking CE alone or in combination with MPA.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Endometrial carcinoma: The use of unopposed estrogen in women with an intact uterus is associated with an increased risk of endometrial cancer. The addition of a progestin to estrogen therapy may decrease the risk of endometrial hyperplasia, a precursor to endometrial cancer. Adequate diagnostic measures, including endometrial sampling if indicated, should be performed to rule out malignancy in postmenopausal women with undiagnosed abnormal vaginal bleeding. Estrogens may exacerbate endometriosis. Malignant transformation of residual endometrial implants has been reported posthysterectomy with unopposed estrogen therapy. Consider adding a progestin in women with residual endometriosis posthysterectomy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Inherited thrombophilia: Women with inherited thrombophilias (eg, protein C or S deficiency) may have increased risk of venous thromboembolism (DeSancho, 2010; van Vlijmen, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Lipid effects: Estrogen compounds are generally associated with lipid effects such as increased HDL-cholesterol and decreased LDL-cholesterol. Triglycerides may also be increased; use with caution in patients with familial defects of lipoprotein metabolism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ovarian cancer: Postmenopausal estrogen therapy and combined estrogen/progesterone therapy may increase the risk of ovarian cancer; however, the absolute risk to an individual woman is small. Although results from various studies are not consistent, risk does not appear to be significantly associated with the duration, route, or dose of therapy. In one study, the risk decreased after 2 years following discontinuation of therapy (M&oslash;rch, 2009). Although the risk of ovarian cancer is rare, women who are at an increased risk (eg, family history) should be counseled about the association (NAMS, 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Retinal vascular thrombosis: Estrogens may cause retinal vascular thrombosis; discontinue if migraine, loss of vision, proptosis, diplopia, or other visual disturbances occur; discontinue permanently if papilledema or retinal vascular lesions are observed on examination.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Use caution in patients with asthma; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Carbohydrate intolerance: May have adverse effects on glucose tolerance; use caution in women with diabetes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease:",
"     <b>",
"      [U.S. Boxed Warning]: Estrogens with or without progestin should not be used to prevent cardiovascular disease.",
"     </b>",
"     Using data from the Women&rsquo;s Health Initiative (WHI) studies, an increased risk of deep vein thrombosis (DVT) and stroke has been reported with CE and an increased risk of DVT, stroke, pulmonary emboli (PE) and myocardial infarction (MI) has been reported with CE with MPA in postmenopausal women. Additional risk factors include diabetes mellitus, hypercholesterolemia, hypertension, SLE, obesity, tobacco use, and/or history of venous thromboembolism (VTE). Risk factors should be managed appropriately; discontinue use if adverse cardiovascular events occur or are suspected.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diseases exacerbated by fluid retention: Use with caution in patients with diseases which may be exacerbated by fluid retention, including cardiac or renal dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Epilepsy: Use caution with epilepsy; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gallbladder disease: Use of postmenopausal estrogen may be associated with an increased risk of gallbladder disease requiring surgery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic dysfunction: Estrogens are poorly metabolized in patients with hepatic dysfunction. Use caution with a history of cholestatic jaundice associated with prior estrogen use or pregnancy. Discontinue if jaundice develops or if acute or chronic hepatic disturbances occur. Use is contraindicated with hepatic disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic hemangiomas: Use with caution in patients with hepatic hemangiomas; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hereditary angioedema: Exogenous estrogens may exacerbate angioedema symptoms in women with hereditary angioedema.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypocalcemia: Use with caution in patients with severe hypocalcemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Migraine: Use caution with migraine; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Porphyria: Use with caution in patients with porphyria; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; SLE: Use with caution in patients with SLE; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid replacement therapy: Estrogens may increase thyroid-binding globulin (TBG) levels leading to increased circulating total thyroid hormone levels. Women on thyroid replacement therapy may require higher doses of thyroid hormone while receiving estrogens.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Surgical patients: Whenever possible, should be discontinued at least 4-6 weeks prior to elective surgery associated with an increased risk of thromboembolism or during periods of prolonged immobilization.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Laboratory changes: The use of estrogens and/or progestins may change the results of some laboratory tests (eg, coagulation factors, lipids, glucose tolerance, binding proteins). The dose, route, and the specific estrogen/progestin influences these changes. In addition, personal risk factors (eg, cardiovascular disease, smoking, diabetes, age) also contribute to adverse events; use of specific products may be contraindicated in women with certain risk factors.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Osteoporosis use: For use only in women at significant risk of osteoporosis and for who other nonestrogen medications are not considered appropriate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Risks vs benefits:",
"     <b>",
"      [U.S. Boxed Warning]: Estrogens with or without progestin should be used for the shortest duration possible at the lowest effective dose consistent with treatment goals.",
"     </b>",
"     Before prescribing estrogen therapy to postmenopausal women, the risks and benefits must be weighed for each patient. Women should be informed of these risks and benefits, as well as possible effects of progestin when added to estrogen therapy. Patients should be reevaluated as clinically appropriate to determine if treatment is still necessary. Available data related to treatment risks are from Women&rsquo;s Health Initiative (WHI) studies, which evaluated oral CE 0.625 mg with or without MPA 2.5 mg relative to placebo in postmenopausal women. Other combinations and dosage forms of estrogens and progestins were not studied.",
"     <b>",
"      Outcomes reported from clinical trials using CE with or without MPA should be assumed to be similar for other doses and other dosage forms of estrogens and progestins until comparable data becomes available.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vulvar and vaginal atrophy use: When used solely for the treatment of vulvar and vaginal atrophy, topical vaginal products should be considered.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F167197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F167165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anastrozole: Estrogen Derivatives may diminish the therapeutic effect of Anastrozole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inducers may decrease the serum concentration of ARIPiprazole.  Management: Double the oral aripiprazole dose and closely monitor clinical response.  Reduce the oral aripiprazole dose to 10-15 mg/day if the inducer is discontinued. Avoid use of CYP3A4 inducers for more than 14 days with extended-release injectable aripiprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ascorbic Acid: May increase the serum concentration of Estrogen Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Axitinib: CYP3A4 Inducers (Weakly to Moderately Effective) may decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chenodiol: Estrogen Derivatives may diminish the therapeutic effect of Chenodiol.  Management: Monitor clinical response to chenodiol closely when used together with any estrogen derivative.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Estrogen Derivatives may increase the serum concentration of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Estrogenic Properties): May enhance the adverse/toxic effect of Estrogen Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Estrogen Derivatives may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving estrogens (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (COX-2 Inhibitor): May enhance the thrombogenic effect of Estrogen Derivatives. NSAID (COX-2 Inhibitor) may increase the serum concentration of Estrogen Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ospemifene: Estrogen Derivatives may enhance the adverse/toxic effect of Ospemifene. Estrogen Derivatives may diminish the therapeutic effect of Ospemifene.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: Estrogen Derivatives may increase the serum concentration of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Somatropin: Estrogen Derivatives may diminish the therapeutic effect of Somatropin. Shown to be a concern with oral hormone replacement therapy in postmenopausal women.  Management: Monitor for reduced growth hormone efficacy. A larger somatropin dose may be required to reach treatment goal.  This interaction does not appear to apply to non-orally administered estrogens (e.g., transdermal, vaginal ring).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thyroid Products: Estrogen Derivatives may diminish the therapeutic effect of Thyroid Products.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: Estrogen Derivatives may enhance the dermatologic adverse effect of Tipranavir. The combination of tipranavir/ritonavir and ethinyl estradiol/norethindrone was associated with a high incidence of skin rash. Tipranavir may decrease the serum concentration of Estrogen Derivatives.  Management: Women using hormonal contraceptives should consider alternative, non-hormonal forms of contraception.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ursodiol: Estrogen Derivatives may diminish the therapeutic effect of Ursodiol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F167184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Avoid ethanol (routine use increases estrogen level and risk of breast cancer). Ethanol may also increase the risk of osteoporosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Folic acid absorption may be decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: St John's wort may decrease estradiol levels. Avoid black cohosh, dong quai (has estrogenic activity). Avoid red clover, saw palmetto, ginseng.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F167178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not for use prior to menopause; use during pregnancy is contraindicated.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F167192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F4145989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Estrogens may decrease the quality and quantity of breast milk.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F167177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Patch, twice-weekly",
"     </b>",
"     (CombiPatch Transdermal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05-0.14 mg/day (1): $10.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05-0.25 mg/day (1): $10.49",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Activella Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.5-0.1 mg (28): $138.32",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-0.5 mg (28): $152.04",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Estradiol-Norethindrone Acet Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.5-0.1 mg (28): $102.93",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-0.5 mg (28): $107.48",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Mimvey Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-0.5 mg (28): $113.19",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F167168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Routine physical examination that includes blood pressure and Papanicolaou smear, breast exam, mammogram. Monitor for signs of endometrial cancer. Adequate diagnostic measures, including endometrial sampling, if indicated, should be performed to rule out malignancy in all cases of undiagnosed abnormal vaginal bleeding. Monitor for loss of vision, sudden onset of proptosis, diplopia, migraine; signs and symptoms of thromboembolic disorders; glycemic control in patients with diabetes; lipid profiles in patients being treated for hyperlipidemias; thyroid function in patients on thyroid hormone replacement therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Menopausal symptoms: Assess need for therapy at 3- to 6-month intervals",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Prevention of osteoporosis: Bone density measurement",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F167179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Activelle (AR, CH, DK, FI, FR, HK, IL, KP, SE, SG, TW, UY);",
"     </li>",
"     <li>",
"      Clibon (DO, GT, HN, NI);",
"     </li>",
"     <li>",
"      Clinorette (GB, IE);",
"     </li>",
"     <li>",
"      Covina (TW);",
"     </li>",
"     <li>",
"      Estalis continuous (AU);",
"     </li>",
"     <li>",
"      Estalis Sequi (AU);",
"     </li>",
"     <li>",
"      Estracomb (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Estragest TTS (AE, BH, CY, DE, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Eveclin Half (KP);",
"     </li>",
"     <li>",
"      Eviana (IL);",
"     </li>",
"     <li>",
"      Eviclin (KP);",
"     </li>",
"     <li>",
"      Evorel Cont (IL);",
"     </li>",
"     <li>",
"      Evorel Conti (AR);",
"     </li>",
"     <li>",
"      Evorel Sequi (IL);",
"     </li>",
"     <li>",
"      Heana (TW);",
"     </li>",
"     <li>",
"      Kliogest (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, PK, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Kliovance (AU, NZ);",
"     </li>",
"     <li>",
"      Novofem (CL, EE, GB, HK, IE);",
"     </li>",
"     <li>",
"      Tri-Sequens (KP, SG);",
"     </li>",
"     <li>",
"      Trisekvens (SE);",
"     </li>",
"     <li>",
"      Trisequens (BF, BG, BJ, BR, CH, CI, CN, ET, FR, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, PY, SC, SD, SL, SN, TN, TZ, UG, UY, ZM, ZW);",
"     </li>",
"     <li>",
"      Trisequens Forte (IL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F167174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     See individual agents.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Activella&reg;:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bioavailability: Estradiol: 50%; Norethindrone: 100%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Half-life elimination: Estradiol: 12-14 hours; Norethindrone: 8-11 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Time to peak: Estradiol: 5-8 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Anderson GL, Chlebowski RT, Aragaki AK, et al, \"Conjugated Equine Oestrogen and Breast Cancer Incidence and Mortality in Postmenopausal Women With Hysterectomy: Extended Follow-Up of the Women's Health Initiative Randomised Placebo-Controlled Trial,\"",
"      <i>",
"       Lancet Oncol,",
"      </i>",
"      2012,13(5):476-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38823/abstract-text/22401913/pubmed\" id=\"22401913\" target=\"_blank\">",
"        22401913",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Anderson GL, Limacher M, Assaf AR, et al, \"Effects of Conjugated Equine Estrogen In Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial.\"",
"      <i>",
"       JAMA",
"      </i>",
"      , 2004, 291(14):1701-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38823/abstract-text/15082697/pubmed\" id=\"15082697\" target=\"_blank\">",
"        15082697",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chlebowski RT, Kuller LH, Prentice RL, et al, \"Breast Cancer After Use of Estrogen Plus Progestin in Postmenopausal Women,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2009, 360(6):573-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38823/abstract-text/19196674/pubmed\" id=\"19196674\" target=\"_blank\">",
"        19196674",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      DeSancho MT, Dorff T, and Rand JH, \"Thrombophilia and the Risk of Thromboembolic Events In Women on Oral Contraceptives and Hormone Replacement Therapy,\"",
"      <i>",
"       Blood Coagul Fibrinolysis",
"      </i>",
"      , 2010, 21(6):534-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38823/abstract-text/20581664/pubmed\" id=\"20581664\" target=\"_blank\">",
"        20581664",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hsia J, Langer RD, Manson JE, et al, \"Conjugated Equine Estrogens and Coronary Heart Disease: The Women's Health Initiative,\"",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 2006, 166(3):357-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38823/abstract-text/16476878/pubmed\" id=\"16476878\" target=\"_blank\">",
"        16476878",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      M&oslash;rch LS, L&oslash;kkegaard E, Andreasen AH, et al, &ldquo;Hormone Therapy and Ovarian Cancer,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2009, 302(3):298-305.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38823/abstract-text/19602689/pubmed\" id=\"19602689\" target=\"_blank\">",
"        19602689",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      North American Menopause Society [NAMS], \"The 2012 Hormone Therapy Position Statement of The North American Menopause Society,\"",
"      <i>",
"       Menopause",
"      </i>",
"      , 2012, 19(3):257-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38823/abstract-text/22367731/pubmed\" id=\"22367731\" target=\"_blank\">",
"        22367731",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shumaker SA, Legault C, Rapp SR, et al, &ldquo;Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289(20):2651-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38823/abstract-text/12771112/pubmed\" id=\"12771112\" target=\"_blank\">",
"        12771112",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rossouw JE, Anderson GL, Prentice RL, et al, &ldquo;Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principle Results From the Women's Health Initiative Randomized Controlled Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2002, 288(3):321-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38823/abstract-text/12117397/pubmed\" id=\"12117397\" target=\"_blank\">",
"        12117397",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      U.S. Food and Drug Administration, Department of Health and Human Services, &ldquo;WHIMS Study on Estrogen/Progestin,&rdquo; May 27, 2003. Available at",
"      <a href=\"file://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm135318.htm\" target=\"_blank\">",
"       file://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm135318.htm",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van Vlijmen EF, Veeger NJ, Middeldorp S, et al, \"Thrombotic Risk During Oral Contraceptive Use and Pregnancy in Women With Factor V Leiden or Prothrombin Mutation: A Rational Approach to Contraception,\"",
"      <i>",
"       Blood",
"      </i>",
"      , 2011, 118(8):2055-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/58/38823/abstract-text/21659542/pubmed\" id=\"21659542\" target=\"_blank\">",
"        21659542",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8924 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-06EB330AA9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38823=[""].join("\n");
var outline_f37_58_38823=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708751\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167186\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167187\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167201\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167188\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167189\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15837941\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15837942\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167170\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10241398\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167158\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167172\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167171\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167199\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167175\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167161\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167197\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167165\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167184\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167178\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167192\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4145989\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167177\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167168\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167179\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167174\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8924\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8924|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?0/7/113?source=related_link\">",
"      Estradiol and norethindrone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_58_38824="Estradiol (systemic): Patient drug information";
var content_f37_58_38824=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Estradiol (systemic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/25/14746?source=see_link\">",
"     see \"Estradiol (systemic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/35/35383?source=see_link\">",
"     see \"Estradiol (systemic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8018338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alora&reg;;",
"     </li>",
"     <li>",
"      Climara&reg;;",
"     </li>",
"     <li>",
"      Delestrogen&reg;;",
"     </li>",
"     <li>",
"      Depo&reg;-Estradiol;",
"     </li>",
"     <li>",
"      Divigel&reg;;",
"     </li>",
"     <li>",
"      Elestrin&reg;;",
"     </li>",
"     <li>",
"      Estrace&reg;;",
"     </li>",
"     <li>",
"      Estrasorb&reg;;",
"     </li>",
"     <li>",
"      EstroGel&reg;;",
"     </li>",
"     <li>",
"      Evamist&reg;;",
"     </li>",
"     <li>",
"      Femring&reg;;",
"     </li>",
"     <li>",
"      Femtrace&reg;;",
"     </li>",
"     <li>",
"      Menostar&reg;;",
"     </li>",
"     <li>",
"      Minivelle&trade;;",
"     </li>",
"     <li>",
"      Vivelle-Dot&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8018339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Climara&reg;;",
"     </li>",
"     <li>",
"      Depo&reg;-Estradiol;",
"     </li>",
"     <li>",
"      Estraderm&reg;;",
"     </li>",
"     <li>",
"      Estradot&reg;;",
"     </li>",
"     <li>",
"      EstroGel&reg;;",
"     </li>",
"     <li>",
"      Menostar&reg;;",
"     </li>",
"     <li>",
"      Oesclim&reg;;",
"     </li>",
"     <li>",
"      Sandoz-Estradiol Derm 100;",
"     </li>",
"     <li>",
"      Sandoz-Estradiol Derm 50;",
"     </li>",
"     <li>",
"      Sandoz-Estradiol Derm 75",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027404\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700311",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Estrogens, when used in women after stopping periods (menopause), may raise the chance of uterine cancer. Progestins may lower this chance. A warning sign for cancer of the uterus is vaginal bleeding. Report any vaginal bleeding to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take estrogens if you are pregnant. If you get pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700259",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take estrogens to stop heart disease or dementia. Using estrogens may raise your chances of having a heart attack, a stroke, breast cancer, or a blood clot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3406344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use estrogens with or without progestin for the shortest time needed at the lowest useful dose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2847064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not let any other person touch the spray or the treated part of your skin.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691539",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put off soft, brittle bones (osteoporosis) in women after change of life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691649",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or lower the signs of stopping periods (menopause).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692003",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used when the ovaries have been taken out, are not working the right way, or have stopped working.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rarely, it is used to treat breast or prostate cancers.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027405\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to estradiol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703380",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Bleeding disorder, blood clots, breast cancer (except in some cases where the cancer has spread), liver disease, recent heart attack, recent stroke, tumor where estrogen makes it grow, or vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703789",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have surgery and need bed rest.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701043",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to tartrazine, talk with your doctor. Some products have tartrazine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697661",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There may be a higher chance of endometrial or breast cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have gallbladder disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high calcium levels, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697245",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had high triglyceride levels, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697308",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have migraine headaches, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have a bone density test. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698554",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do monthly breast self-exams and have a gynecologic exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort, dong quai, black cohosh, saw palmetto, red clover, or ginseng with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid cigarette smoking. People older than 35 years of age and/or smoking more than 15 cigarettes per day have more chance for heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705536",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin emulsion:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696731",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use sunscreen on legs before using emulsion or soon after using emulsion.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705537",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin gel:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696729",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use sunscreen before using gel or soon after using gel.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696730",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use sunscreen on gel part for 7 days in a row.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin spray:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696606",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use sunscreen 1 hour before using spray.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2847065",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If a child touches the spray, she/he needs to wash the skin with soap and water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The patch may have metal. Take off the patch before an MRI.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027411\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698113",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697923",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Enlarged breasts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gallbladder disease, blood clots, heart attacks, and other blood vessel problems may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027413\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698615",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in how contact lenses feel in the eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698598",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A lump in the breast or breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2849880",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs that your child was exposed to the spray. These include early puberty and enlarged sex organs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10434322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695956",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There may be days when you will not take this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705494",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Soft, brittle bones (osteoporosis):",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696101",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug works best when used with calcium/vitamin D and weight-bearing workouts like walking or PT (physical therapy).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705536",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin emulsion:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694513",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on clean, dry, healthy skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694447",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put contents of 1 pouch on 1 thigh. Rub into thigh and calf.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694448",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put contents of the second pouch on the other thigh. Rub into thigh and calf.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694451",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put any emulsion left on your hands on the buttocks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696254",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Let dry before covering with clothing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705537",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin gel:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705370",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Divigel&reg;:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694511",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on clean, dry, healthy skin on the thigh.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695476",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Move the site with each packet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694685",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on the face, breast, or vagina.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694469",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put over 5 x 7 inches.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696254",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694689",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not bathe, shower, or swim for 1 hour after putting on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Let dry before covering with clothing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705382",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         EstroGel&reg;:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Prime pump before first use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694503",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on clean, dry, healthy skin of 1 arm from the wrist to the shoulder.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694458",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on gel at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694692",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not bathe, shower, or swim right after putting on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696254",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Let dry before covering with clothing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid fire, flames, or smoking until the gel has dried.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705377",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Elestrin&reg;:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695542",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Prime pump 10 times before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694504",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on clean, dry, healthy skin of upper arm and shoulder.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694559",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bathe or shower before putting on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694757",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not swim for 2 hours after putting on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694514",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put patch on clean, dry, healthy skin. Move the site with each new patch.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694736",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not place on breast.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695146",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If the patch falls off, put a new one on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin spray:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695545",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Prime pump by spraying it 3 times.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695093",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hold container upright and rest plastic cone flat on the skin while spraying.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694501",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on clean, dry, healthy skin of the inner forearm. Start near the elbow.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694492",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use spray at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Let dry before covering with clothing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3567482",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not rub into skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694689",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not bathe, shower, or swim for 1 hour after putting on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694538",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid fire, flames, or smoking until dry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705577",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Vaginal ring:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695236",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put into the vagina and leave in place for 90 days.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694870",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to use as you have been told by your doctor or read the package insert.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695580",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out ring at the start of the 13th week.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695226",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put in a new ring.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To use, wash your hands and take ring from the pouch.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Press sides of ring at the same time between thumb and index finger and put folded ring into the vagina.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695506",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Perfect placement is not needed for the ring to work. The ring will not hurt.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696146",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To take off, hook your index finger around the rim or hold rim between index finger and middle finger and pull out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694778",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not throw the vaginal ring in the toilet.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027409\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696442",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed patch as soon as you think about it after taking off the old one.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Start a new timetable after the patch is put back on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027414\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027415\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11674 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-115.25.216.6-E05BAE8337-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38824=[""].join("\n");
var outline_f37_58_38824=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8018338\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8018339\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027404\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027406\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027405\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027410\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027411\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027413\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10434322\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027409\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027414\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027415\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?14/25/14746?source=related_link\">",
"      Estradiol (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/35/35383?source=related_link\">",
"      Estradiol (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?38/1/38935?source=related_link\">",
"      Estradiol (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?39/34/40485?source=related_link\">",
"      Estradiol (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_58_38825="Plasma cell vulvitis1";
var content_f37_58_38825=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F75171%7EOBGYN%2F51099&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F75171%7EOBGYN%2F51099&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plasma cell vulvitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 345px; height: 429px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plasma cell vulvitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 318px; height: 468px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38825=[""].join("\n");
var outline_f37_58_38825=null;
var title_f37_58_38826="Disseminated granuloma annulare - annular lesions";
var content_f37_58_38826=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F71308%7EDERM%2F77002%7EDERM%2F51459%7EDERM%2F64223%7EDERM%2F53172%7EDERM%2F53898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F71308%7EDERM%2F77002%7EDERM%2F51459%7EDERM%2F64223%7EDERM%2F53172%7EDERM%2F53898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Disseminated granuloma annulare",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 346px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 42 year-old patient with disseminated granuloma annulare presented with 200 annular lesions ranging from 5-25 mm in diameter on the arms, legs, and trunk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Disseminated granuloma annulare",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 376px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 55 year-old patient presented with disseminated granuloma annulare in a brightly erythematous annular and arcuate pattern demonstrating complete central clearing. Scores of similar lesions were present on the trunk and extremities sparing the face, palms, and soles.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Disseminated granuloma annulare",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 381px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 60 year-old patient with disseminated granuloma annulare presented with hundreds of erythematous papules and plaques on the medial arms, medial thighs, and buttocks. None of the lesions showed central clearing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Disseminated granuloma annulare",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 64 year-old woman with disseminated granuloma annulare displays solitary papules and incomplete annular lesions composed of discrete papules at the periphery of the rings.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Disseminated granuloma annulare",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 316px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 40 year-old patient presented with over 100 discrete 1-2 mm erythematous papules over the arms and legs with just a few similar lesions on the trunk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Granuloma annulare",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 370px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 30 year-old patient with disseminated granuloma annulare shows confluent annular lesions on the right dorsum foot with papules at the periphery and within the center of the patches. Similar patchy involvement was present on the legs, hands, arms, and buttocks.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38826=[""].join("\n");
var outline_f37_58_38826=null;
var title_f37_58_38827="Actions extraocular muscles";
var content_f37_58_38827=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F72952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F72952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Actions of extraocular muscles",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Nerve and muscle",
"       </td>",
"       <td class=\"subtitle1\">",
"        Primary action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Secondary action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Tertiary action",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Cranial nerve III&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Superior rectus",
"       </td>",
"       <td>",
"        Elevation (maximal on lateral gaze)",
"       </td>",
"       <td>",
"        Intorsion",
"       </td>",
"       <td>",
"        Adduction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Inferior rectus",
"       </td>",
"       <td>",
"        Depression (maximal on lateral gaze)",
"       </td>",
"       <td>",
"        Extorsion",
"       </td>",
"       <td>",
"        Adduction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Medial rectus",
"       </td>",
"       <td>",
"        Adduction",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        None",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Inferior oblique",
"       </td>",
"       <td>",
"        Excyclotorsion",
"       </td>",
"       <td>",
"        Elevation (maximal on medial gaze)",
"       </td>",
"       <td>",
"        Abduction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Cranial nerve IV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Superior oblique",
"       </td>",
"       <td>",
"        Incyclotorsion",
"       </td>",
"       <td>",
"        Depression (maximal on medial gaze)",
"       </td>",
"       <td>",
"        Abduction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Cranial nerve VI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lateral rectus",
"       </td>",
"       <td>",
"        Abduction",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        None",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38827=[""].join("\n");
var outline_f37_58_38827=null;
var title_f37_58_38828="Clinical manifestations of mono";
var content_f37_58_38828=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F57448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F57448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical manifestations of infectious mononucleosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Symptoms and signs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Malaise and fatigue",
"       </td>",
"       <td>",
"        90-100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sweats",
"       </td>",
"       <td>",
"        80-95",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sore throat, dysphagia",
"       </td>",
"       <td>",
"        80-85",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anorexia",
"       </td>",
"       <td>",
"        50-80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nausea",
"       </td>",
"       <td>",
"        50-70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Headache",
"       </td>",
"       <td>",
"        40-70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chills",
"       </td>",
"       <td>",
"        40-60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cough",
"       </td>",
"       <td>",
"        30-50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myalgia",
"       </td>",
"       <td>",
"        12-30",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ocular muscle pain",
"       </td>",
"       <td>",
"        10-20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chest pain",
"       </td>",
"       <td>",
"        5-20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Arthralgia",
"       </td>",
"       <td>",
"        5-10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Photophobia",
"       </td>",
"       <td>",
"        5-10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Signs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Adenopathy",
"       </td>",
"       <td>",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fever",
"       </td>",
"       <td>",
"        80-95",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pharyngitis",
"       </td>",
"       <td>",
"        65-85",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Splenomegaly",
"       </td>",
"       <td>",
"        50-60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bradycardia",
"       </td>",
"       <td>",
"        35-50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Periorbital edema",
"       </td>",
"       <td>",
"        25-40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Palatal enanthem",
"       </td>",
"       <td>",
"        25-35",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Liver and spleen tenderness",
"       </td>",
"       <td>",
"        15-30",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatomegaly",
"       </td>",
"       <td>",
"        15-25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rhinitis",
"       </td>",
"       <td>",
"        10-25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Jaundice",
"       </td>",
"       <td>",
"        5-10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Skin rash",
"       </td>",
"       <td>",
"        3-6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pneumonitis",
"       </td>",
"       <td>",
"        &lt;3",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from Chervenik, PA. Dis Mon 1974; 1:29.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38828=[""].join("\n");
var outline_f37_58_38828=null;
var title_f37_58_38829="Marsupialized pilonidal wound closure";
var content_f37_58_38829=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F87172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F87172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Marsupialized pilonidal wound closure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 298px; height: 262px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The pilonidal disease has been completely excised. The wound is partially closed by marsupializing the skin edges to the sacrococcygeal fascia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38829=[""].join("\n");
var outline_f37_58_38829=null;
var title_f37_58_38830="Proposed classification of MPGN";
var content_f37_58_38830=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F86556&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F86556&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 497px\">",
"   <div class=\"ttl\">",
"    Proposed classification of MPGN",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 477px; height: 415px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br/>",
"     <ol>",
"      <li>",
"       Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis--a new look at an old entity. N Engl J Med 2012; 366:1119.",
"      </li>",
"      <li>",
"       Fervenza FC, Sethi S, Glassock RJ. Idiopathic membranoproliferative glomerulonephritis: does it exist? Nephrol Dial Transplant 2012.",
"      </li>",
"     </ol>",
"     Algorithm created by Sanjeev Sethi, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38830=[""].join("\n");
var outline_f37_58_38830=null;
var title_f37_58_38831="Calcifications mature teratoma";
var content_f37_58_38831=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F66911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F66911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mature cystic ovarian teratoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 245px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plain film of the abdomen reveals calcifications in the area of the ovary, suggestive of the diagnosis of a mature cystic teratoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Mitchel Hoffman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_58_38831=[""].join("\n");
var outline_f37_58_38831=null;
